Literature DB >> 20619718

Cytokine-receptor interactions as drug targets.

Gideon Schreiber1, Mark R Walter.   

Abstract

Cytokines are essential proteins that exert potent control over entire cell populations to fight infections and other pathologies, but can by themselves cause disease. Therefore, cytokine-related drugs act either by stimulating or blocking their activities. Our knowledge of the structures of cytokine-receptor complexes, the biophysical basis of their binding, and their mode of biological activation has substantially increased in recent years. This knowledge has been translated into new drugs and drug candidates. This review summarizes our current understanding of the receptor-mediated activity of cytokines, their relation to health and disease, and the agents in use to activate and block their actions. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619718      PMCID: PMC2918676          DOI: 10.1016/j.cbpa.2010.06.165

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  77 in total

Review 1.  The road less traveled: modulating signal transduction enzymes by inhibiting their protein-protein interactions.

Authors:  Michelle R Arkin; Adrian Whitty
Journal:  Curr Opin Chem Biol       Date:  2009-06-22       Impact factor: 8.822

2.  Non-random distribution of interleukin receptors on the cell surface.

Authors:  Attila Jenei; József Kormos; Gergely Szentesi; Adrienn J Veres; Sándor Varga; Andrea Bodnár; Sándor Damjanovich; László Mátyus
Journal:  Chemphyschem       Date:  2009-07-13       Impact factor: 3.102

3.  Structure of IL-17A in complex with a potent, fully human neutralizing antibody.

Authors:  Stefan Gerhardt; W Mark Abbott; David Hargreaves; Richard A Pauptit; Rick A Davies; Maurice R C Needham; Caroline Langham; Wendy Barker; Azad Aziz; Melanie J Snow; Sarah Dawson; Fraser Welsh; Trevor Wilkinson; Tris Vaugan; Gerald Beste; Sarah Bishop; Bojana Popovic; Gareth Rees; Matthew Sleeman; Steven J Tuske; Stephen J Coales; Yoshitomo Hamuro; Caroline Russell
Journal:  J Mol Biol       Date:  2009-10-14       Impact factor: 5.469

4.  Receptor density is key to the alpha2/beta interferon differential activities.

Authors:  Ignacio Moraga; Daniel Harari; Gideon Schreiber; Gilles Uzé; Sandra Pellegrini
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

Review 5.  Long interspersed nuclear elements (LINE-1): potential triggers of systemic autoimmune disease.

Authors:  Mary K Crow
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

6.  Crystal structure of a soluble decoy receptor IL-22BP bound to interleukin-22.

Authors:  Patricia Ribeiro de Moura; Leandra Watanabe; Lucas Bleicher; Didier Colau; Laure Dumoutier; Muriel M Lemaire; Jean-Christophe Renauld; Igor Polikarpov
Journal:  FEBS Lett       Date:  2009-03-11       Impact factor: 4.124

7.  Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.

Authors:  Yihong Yao; Laura Richman; Brandon W Higgs; Christopher A Morehouse; Melissa de los Reyes; Philip Brohawn; Jianliang Zhang; Barbara White; Anthony J Coyle; Peter A Kiener; Bahija Jallal
Journal:  Arthritis Rheum       Date:  2009-06

8.  NMR mapping of the IFNAR1-EC binding site on IFNalpha2 reveals allosteric changes in the IFNAR2-EC binding site.

Authors:  Sabine Ruth Akabayov; Zohar Biron; Peter Lamken; Jacob Piehler; Jacob Anglister
Journal:  Biochemistry       Date:  2010-02-02       Impact factor: 3.162

Review 9.  Aicardi-Goutieres syndrome and related phenotypes: linking nucleic acid metabolism with autoimmunity.

Authors:  Yanick J Crow; Jan Rehwinkel
Journal:  Hum Mol Genet       Date:  2009-10-15       Impact factor: 6.150

Review 10.  Dual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapy.

Authors:  N M Luheshi; N J Rothwell; D Brough
Journal:  Br J Pharmacol       Date:  2009-08       Impact factor: 8.739

View more
  20 in total

1.  Structural reorganization of the interleukin-7 signaling complex.

Authors:  Craig A McElroy; Paul J Holland; Peng Zhao; Jae-Min Lim; Lance Wells; Edward Eisenstein; Scott T R Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Molecular engineering strategies for visualizing low-affinity protein complexes.

Authors:  Qianqian Ming; David Gonzalez-Perez; Vincent C Luca
Journal:  Exp Biol Med (Maywood)       Date:  2019-06-11

3.  Multifaceted activities of type I interferon are revealed by a receptor antagonist.

Authors:  Doron Levin; William M Schneider; Hans-Heinrich Hoffmann; Ganit Yarden; Alberto Giovanni Busetto; Ohad Manor; Nanaocha Sharma; Charles M Rice; Gideon Schreiber
Journal:  Sci Signal       Date:  2014-05-27       Impact factor: 8.192

Review 4.  Structural insights into the common γ-chain family of cytokines and receptors from the interleukin-7 pathway.

Authors:  Scott T R Walsh
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

5.  Determination of half-maximal inhibitory concentration using biosensor-based protein interaction analysis.

Authors:  Senem Aykul; Erik Martinez-Hackert
Journal:  Anal Biochem       Date:  2016-06-27       Impact factor: 3.365

6.  From proteomics to discovery of first-in-class ST2 inhibitors active in vivo.

Authors:  Abdulraouf M Ramadan; Etienne Daguindau; Jason C Rech; Krishnapriya Chinnaswamy; Jilu Zhang; Greg L Hura; Brad Griesenauer; Zachary Bolten; Aaron Robida; Martha Larsen; Jeanne A Stuckey; Chao-Yie Yang; Sophie Paczesny
Journal:  JCI Insight       Date:  2018-07-26

7.  CytReD: A database collecting human cytokinome information.

Authors:  Marco Miele; Ankush Sharma; Francesca Capone; Raffaele Raucci; Eliana Guerriero; Giovanni Colonna; Giuseppe Castello; Michele Di Stasio; Susan Costantini
Journal:  Bioinformation       Date:  2011-05-26

8.  Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling.

Authors:  Stephan Wilmes; Oliver Beutel; Zhi Li; Véronique Francois-Newton; Christian P Richter; Dennis Janning; Cindy Kroll; Patrizia Hanhart; Katharina Hötte; Changjiang You; Gilles Uzé; Sandra Pellegrini; Jacob Piehler
Journal:  J Cell Biol       Date:  2015-05-25       Impact factor: 10.539

9.  The identification of specific methylation patterns across different cancers.

Authors:  Chunlong Zhang; Hongyan Zhao; Jie Li; Hongbo Liu; Fang Wang; Yanjun Wei; Jianzhong Su; Dongwei Zhang; Tiefu Liu; Yan Zhang
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

Review 10.  Insights into cytokine-receptor interactions from cytokine engineering.

Authors:  Jamie B Spangler; Ignacio Moraga; Juan L Mendoza; K Christopher Garcia
Journal:  Annu Rev Immunol       Date:  2014-12-10       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.